Seeing Is Believing
Healthcare - Sector
IRWD is currently covered by 3 analysts with an average price target of $5.57. This is a potential upside of $2.75 (27.75%) from yesterday's end of day stock price of $4.36.
Ironwood Pharmaceuticals's activity chart (see below) currently has 23 price targets and 24 ratings on display. The stock rating distribution of IRWD is 75% HOLD and 25% BUY.
Analysts average stock forecasts to be materialized ratio is 59.44% with an average time for these price targets to be met of 136.87 days.
Highest price target for IRWD is $10, Lowest price target is $1.7, average price target is $5.57.
Most recent stock forecast was given by from JMP on 26-Feb-2026. First documented stock forecast 11-Dec-2015.
Currently out of the existing stock ratings of IRWD, 3 are a HOLD (75%), 1 are a BUY (25%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 26-Feb-2026
$10
$5.87 (142.13%)
$8
Hold Since 05-Jan-2026
$5
$0.87 (21.07%)
Hold Since 28-Apr-2025
$1.7
$-2.43 (-58.84%)
$1.1
Buy Since 01-Mar-2024
$0.7
$-3.43 (-83.05%)
$17
Hold Since 09-Sep-2024
$1
$-3.13 (-75.79%)
$5
What is IRWD (Ironwood Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on IRWD (Ironwood Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on IRWD (Ironwood Pharmaceuticals)?
Which analyst is the currently most bullish on IRWD (Ironwood Pharmaceuticals)?
Which analyst is the currently most reserved on IRWD (Ironwood Pharmaceuticals)?